Navigation Links
The US Drug Watchdog Now Urges Women Who Suffered A Heart Attack Or Stroke After Using Yaz Yasmin Birth Control Pills To Contact The Johnson Law Group Immediately
Date:12/4/2012

(PRWEB) December 04, 2012

The US Drug Watchdog is the premier private advocacy group in the United States for victims of dangerous pharmaceuticals, or medical devices. The group has launched an aggressive initiative aimed at identifying women who have suffered severe medical side effects while taking Yaz, Yasmin, or Ocella birth control pills. As a background, in September of 2009, the US FDA has strongly criticized the drug maker for failing to highlight the risk factors associated with these birth control pills. These risk factors, or severe side effects include heart attacks, strokes, blood clotting, pulmonary embolisms, and other serious medical issues. If a user of the birth control pills called Yaz, Yasmin, or Ocella has had a pulmonary embolism, a heart attack, stroke, blood clotting, or other serious medical issues, the US Drug Watchdog is urging victims, or family members of victims to contact the Johnson Law Group at 1-800-996-9900, or to contact this law firm via their web site at http://www.johnsonlawgroup.com/

The US Drug Watchdog says the following side effects have been associated Yaz, Yasmin, or Ocella:

  • Yaz / Yasmin Stroke or Heart attack
  • Yaz / Yasmin Pulmonary Embolism
  • Yaz / Yasmin Deep Vein Thrombosis
  • Yaz / Yasmin Blood Clots
  • Sudden Death from Yaz or Yasmin

The US Drug Watchdog says, "One of the biggest problems we have with respect to our drug initiative work, is the average US consumer never hears about a drug recall, or serious side effects related to a specific drug's use. We are attempting to change this very sad fact with aggressive initiatives focused on increasing public awareness, and hopefully suggesting possible help for victims." http://USDrugWatchdog.Com

MDL No. 2100 (3:09-md-02100-DRH-PMF)

Read the full story at http://www.prweb.com/releases/2012/12/prweb10172409.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. US Drug Watchdog Now Fears the Numbers of Transvaginal Mesh Product Failure Victims Will Grow and They Offer Victims the Names of the Best Lawyers-Who Will All Be Women
2. US Drug Watchdog Now Urges All DePuy Pinnacle Hip Implant Recipients To Get A Blood Test For Elevated Levels Of Cobalt Or Chromium and to Call Them If The Levels Are high
3. The US Drug Watchdog Now Warns Time Could Run Out to Get Women Yaz or Yasmin Birth Control Pill Users Identified if they Suffered a Heart Attack Stroke or a Embolism
4. US Drug Watchdog Now Offers to Help All Woman Who Used Fosamax For Osteoporosis and Then Had an Unexplained a Femur Break Get to the Best Attorneys
5. US Drug Watchdog Says Its Critical All DePuy Pinnacle Hip Implant Recipients Know The Symptoms Of A Failure And They Offer The Names Of The Best Attorneys For Victims
6. The US Drug Watchdog Now Offers To Help All Recipients Of Recalled DePuy ASR Hip Implant Get To The Best Attorneys Because Time Could Run Out To Get Them Identified
7. US Drug Watchdog Now Offers To Help All Recalled DePuy ASR Hip Implant Recipients Get To The Best Attorneys Out Of Fear These Recipients Won't Be Compensated
8. US Drug Watchdog Now Offers Victims of All Metal Hip Implant Failure the Names of the Best Attorneys & Calls Metal Hip Implants a Train Wreck with Up to 500,000 Victims
9. The US Drug Watchdog Now Urges Plaintiffs Law Firms Worldwide To Contact Them About A Possible International Effort To Help Victims Of Defective Drugs Or Medical Devices
10. The US Drug Watchdog Now Offers Women Who Had A Heart Attack Or Stroke After Using The Birth Control Pills Yaz Yasmin Birth Control Pills Get To The Best Attorneys
11. US Drug Watchdog Now Offers To Help Women Who Used TheOsteoporosis Drug Called Fosamax And Then Had A Unexplainable Femur Fracture Get To The Best Attorneys Or Law Firms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: